A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer CellsAharon G. Freud, Michael A. Caligiuri, John Sung et al.|Immunity|2005Cited by 382
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) ConsortiumTalal El Zarif, Danai Dima, Amin H. Nassar et al.|Journal of Clinical Oncology|2023Cited by 69
The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative diseaseJohn T. Patton, Robert A. Baiocchi|Oncotarget|2014Cited by 28
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphomaAnuvrat Sircar, Lalit Sehgal, Satishkumar Singh et al.|Leukemia|2023Cited by 13